Alzheimer’s

The therapeutic potential of the endocannabinoid system for Alzheimer’s disease

Endocannabinoid signalling in Alzheimer’s disease

A molecular link between the active component of marijuana and Alzheimer’s disease pathology

Neuroprotective effect of cannabidiol, a non-psychoactive component from Cannabis sativa, on beta-amyloid-induced toxicity in PC12 cells

The Potential Therapeutic Effects of THC on Alzheimer’s Disease

The Role of Endocannabinoid Signaling in the Molecular Mechanisms of Neurodegeneration in Alzheimer’s Disease

Cannabinoids for the treatment of dementia

Cannabidiol in vivo blunts beta-amyloid induced neuroinflammation by suppressing IL-1beta and iNOS expression

Cannabidiol: A promising drug for neurodegenerative disorders?

Cannabinoid receptor 1 deficiency in a mouse model of Alzheimer’s disease leads to enhanced cognitive impairment despite of a reduction in amyloid deposition

The role of the endocannabinoid system in Alzheimer’s disease: facts and hypotheses

The role of phytochemicals in the treatment and prevention of dementia

Cannabinoids for the treatment of dementia

Cannabidiol Promotes Amyloid Precursor Protein Ubiquitination and Reduction of Beta Amyloid Expression in SHSY5YAPP+ Cells Through PPARγ Involvement

Cannabinoids for treatment of Alzheimer’s disease: moving toward the clinic

Can Marijuana Prevent Alzheimer’s?